Pfizer reaches deal on most-favored nation drug pricing

Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue.

Editor's Pick

Top Story Pfizer Reaches Deal on Most-Favored Nation Drug Pricing; Other Pharmas Expected to Follow Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue. Sponsored Discover how Mayo Clinic Platform_Solutions Studio can accelerate the commercialization of your digital health solution. Presented by Presented by Mayo Clinic Platform_Solutions Studio Whether you're ready to build, validate, or deploy your AI solution into clinical workflows, Solutions Studio offers comprehensive technical and business support tailored to your needs. Learn more.

Featured News

The Burgeoning Life Science Ecosystem of North Texas, Anchored by Pegasus Park [Sponsored] At INVEST Digital Health 2025, David Snow, Executive Director of Pegasus Park, discussed building a life science innovation hub and why life science startups at the North Texas campus are more likely to survive, scale, and exit. Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs September has seen a wide range of executive hires, exits, promotions and layoffs across the healthcare industry. For example, Medtronic, Amgen and Kaiser Permanente welcomed new executives. There were also layoffs at organizations including Novo Nordisk and Seattle Children's. Millie Introduces Perimenopause and Menopause Program With Millie's new perimenopause and menopause offerings, patients receive treatments like hormone therapy, non-hormonal medications, vaginal treatments and lifestyle strategies for symptom relief. MedCity FemFwd: How Evvy Is Advancing Women's Health Research In this episode, we're joined by Priyanka Jain, CEO and co-founder of Evvy, a vaginal health company. Jain discusses how Evvy is trying to improve women's health research and what she hopes to achieve as a founding member of the Milken Institute's Women's Health Network. Startup Crystalys Therapeutics Emerges With $205M to Fill a Growing Gap in Gout Treatment Crystalys Therapeutics' gout drug, dotinurad, inhibits a known and validated target for treating the chronic disorder, but in a way that could be safer than other drugs. The oral small molecule was discovered and developed in Japan, where it is approved and has a safety record spanning more than 1 million gout patients. Why Healthcare Mergers Fail and How to Prevent a Costly Collapse Successful mergers don't just consolidate services. They unify people around a shared mission to serve their patients. If we want to see lasting success in healthcare M&A, it's time to stop leading with checklists and start leading with people. The Case for Stronger Clinician Mental Health Support We owe it to those who dedicate their lives to caring for others to ensure that they, too, have access to help when they need it most.

Video   Beyond Traditional, Broken Health Models Daniel Karlin, chief medical officer of MindMed, spoke at DiMe's Healthcare 2030 Summit in Washington, D.C. His company is developing novel treatments for brain health disorders, with a focus on psychiatry, neurology and addiction. Karlin urged healthcare leaders to look beyond existing data and assumptions to create more meaningful, systemic improvements.

Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More.

Resources

Debunked Episode 19: Turmoil at the CDC, Epic's AI Strategy The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe